Global Clinical Trial Management System (CTMS) Market Research Report 2022 - ResearchAndMarkets.com
Retrieved on:
Wednesday, May 18, 2022
Health, Data Management, Technology, Clinical Trials, Software, ZINC, Diabetes, Merck & Co., Pfizer, Clinical data management, Death, Chronic lung disease, Non-communicable disease, Conditional sentence, Food, Degenerative disease, World, Moyamoya disease, Clinical, Fatality, FAO, IHD, Clinical trial, CHEMBL, Stroke, COVID-19, Clinical trial management system, Food and Agriculture Organization, Merck, Research, FDA, Efficiency, Awareness, Time, Biotechnology, WHO, CTMS, III, Congressional Budget Office, NCD, CAGR, Prevalence, Cancer, Data management, Medical device, Pharmaceutical industry, Alphabet
The "Global Clinical Trial Management System (CTMS) Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Global Clinical Trial Management System (CTMS) Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
- The Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to handle clinical trials in clinical research.
- Furthermore, increasing innovative technology developments to reduce the rising cost of clinical trials have resulted in the development of the clinical trial management system.
- Thus, the increasing number of clinical research studies will boost the use of clinical trial management system solutions, therefore increasing market value.